BSEBoard Meeting3 Nov 2026 · 3 Nov 2026, 05:35 pm

Parnax Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve Standalone and Consolidated Un-audited IND- AS Compliant Financial Results along with Limited Review Report for the quarter (Q2) and half year ended 30th September, 2026, pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement, 2015.

Parnax Lab Ltd · 506128

✦ AI SummaryResults

Parnax Lab Ltd has scheduled a Board Meeting on November 12, 2026, to consider and approve Standalone and Consolidated Un-audited IND-AS Compliant Financial Results for Q2 and half year ended September 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Parnax Lab Ltd - 506128 - Board Meeting Intimation for Consideration And Approval Of Financial Results Along With Limited Review Report For The Quarter (Q2) And Half Year Ended 30Th September, 2026.

Attachments (1)

📄

f1d0349b-0594-46c9-9ef5-4b7f146a0af3.pdf

pdf

Download →
View document text
m o emoss Darnax Lab Ltd. Elall _iinfe@pexpepiabicon (Formerly Known as Krishna Deep Trade & Investment Ltd.) Visit us at: www.naxparlab.com CIN No. :L36912MH1982PLC027925 114, BLDG. NO. 8, JOGANI IND. COMPLEX, SION-CHUNABHATTI, MUMBAI - 400 022. INDIA Date: 03r4 November, 2026 The Department of Corporate Service Bombay Stock Exchange Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai - 400 001 Scrip Code: 506128 Sub.: i f Board Meetin; uant to regulation 29 (1) (a) of Listing Obligation an Disclosure Requirements, 2015 Dear Sir, Pursuant to Regulation 29 of Listing Obligation and Disclosure Requirements, 2015, We hereby inform you that a meeting of the Board of Directors of the Company PARNAX LAB LIMITED is schedule to be held on Thursday, November 12, 2026, at the registered office of the Company, inter alia, to transact the following business: 1. To consider and approve Standalone and Consolidated Un-audited IND- AS Compliant Financial Results along with Limited Review Report for the quarter (Q2) and half year ended 30t September, 2026, pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. Any other business with the permission of the Chair. Kindly note that the approved results will be sent to you after the conclusion of the Board meeting. Further in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 and pursuant to the Company’s “Code of Conduct to Regulate, Monitor and Report Trading in Securities of the Company”, the trading window for dealing in the equity shares of the Company has been closed for the concerned persons, w.e.f. October 1, 2026 and the same shall open 48 hours after the declaration of unaudited financial results. Kindly acknowledge the receipt of the same and Oblige Thanking You. Yours truly, For Parnax Lab Limited PREET VIJAY Spisbyiamstorect KUKREJA e 0251103154915 Preet Kukreja Company Secretary & Compliance Officer (Membership No. ACS 56761) Works : Plot No. 120, Masat Ind. Estate, Dadra & Nagar Haveli, Silvassa-396 230 (India) Plot No. 121 & 74, Masat Ind. Estate, Dadra & Nagar Haveli, Silvassa-396 230 (india)